Ministry of Commerce, Jiangsu Province: Support eligible innovative biopharmaceutical companies to raise funds through listing on the Growth Enterprise Market, the Science and Technology Innovation Board, the Beijing Stock Exchange, as well as listing on the New Third Board, and issuing corporate credit bonds.

The Ministry of Commerce and the People's Government of Jiangsu Province have issued the "Open and Innovative Development Plan for the Full Biomedical Industry Chain in China Pilot Free Trade Zones". The plan requires support for innovative bio-pharmaceutical enterprises that meet the conditions to raise funds by listing on the GEM, Sci-Tech Innovation Board, Beijing Stock Exchange, or by being listed on the New Third Board, as well as issuing company credit bonds. Encourage and guide the establishment of bio-pharmaceutical industry investment sub-funds by industry investment funds, venture capital funds, etc. Support bio-pharmaceutical industrial park projects that meet the conditions to issue real estate investment trust funds in the infrastructure sector, and real estate trust asset-backed securities. Establish and improve a market-based research and development risk insurance compensation mechanism in the bio-pharmaceutical field.